Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study

Purpose The purpose of this study is to investigate the association between polypharmacy with health-related quality of life (HRQoL) and medication regimen complexity with HRQoL in residential aged care facilities (RACFs). Methods A cross-sectional study of 383 residents from six Australian RACFs wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical pharmacology 2016-09, Vol.72 (9), p.1117-1124
Hauptverfasser: Lalic, Samanta, Jamsen, Kris M., Wimmer, Barbara C., Tan, Edwin C.K., Hilmer, Sarah N., Robson, Leonie, Emery, Tina, Bell, J. Simon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1124
container_issue 9
container_start_page 1117
container_title European journal of clinical pharmacology
container_volume 72
creator Lalic, Samanta
Jamsen, Kris M.
Wimmer, Barbara C.
Tan, Edwin C.K.
Hilmer, Sarah N.
Robson, Leonie
Emery, Tina
Bell, J. Simon
description Purpose The purpose of this study is to investigate the association between polypharmacy with health-related quality of life (HRQoL) and medication regimen complexity with HRQoL in residential aged care facilities (RACFs). Methods A cross-sectional study of 383 residents from six Australian RACFs was conducted. The primary exposures were polypharmacy (≥9 regular medications) and the validated Medication Regimen Complexity Index (MRCI). The outcome measure was staff informant rated quality of life assessed using the Quality of Life Alzheimer’s disease (QoL-AD) scale. Covariates included age, sex, Charlson’s comorbidity index, activities of daily living, and dementia severity. Logistic quantile regression was used to characterize the association between polypharmacy and QoL-AD (model 1) and MRCI and QoL-AD (model 2). Results The median age of the 383 residents was 88 years and 297 (78 %) residents were female. In total, 63 % of residents were exposed to polypharmacy and the median MRCI score (range) was 43.5 (4–113). After adjusting for the covariates, polypharmacy was not associated with either higher or lower QoL-AD scores (estimate −0.02; 95 % confidence interval (CI) −0.165, 0.124; p  = 0.78). Similarly, after adjusting for the covariates, MRCI was not associated with either higher or lower QoL-AD scores (estimate −0.0009, 95 % CI −0.005, 0.003; p  = 0.63). Conclusions These findings suggest that polypharmacy and medication regimen complexity are not associated with staff informant rated HRQoL. Further research is needed to investigate how specific medication classes may impact change in quality of life over time.
doi_str_mv 10.1007/s00228-016-2075-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1815702894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4144310521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-ce639bbb137194bf66e14cf77f543ef79cd807f84ec1a6c17ff9f8a9e4ae45dd3</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhi0EokvhAbggS1y4BGYcJ465oYoWpEpwgHPkdcZbV0m8tR3BPhTviLNbEEJC4mTL8803tn_GniO8RgD1JgEI0VWAbSVANZV8wDYoa1EhSHzINgA1Vq1WcMaepHQLgI2G-jE7E0o0WLewYT8-h_GwvzFxMvbAzTzwiQZvTfZh5pF2fqKZ2zDtR_rucyESd8bmEFPZpmC9yTTwbz7f8JSNc9zPLhTZnHk8lu4WM66NwfHROyr1ok1-oDmn9dDsCmRNpNXrC-opveWG2xhSqhLZ9SZmLPZlODxlj5wZEz27X8_Z18v3Xy4-VNefrj5evLuurIQmV5baWm-3W6wVarl1bUsorVPKNbImp7QdOlCuk2TRtBaVc9p1RpM0JJthqM_Zq5N3H8PdQin3k0-WxtHMFJbUY4eNAtFp-T8oCt3WUhf05V_obVhiedyRgrZBoVYhnqjjD0Ry_T76ycRDj9Cvsfen2PsSe7_G3q89L-7Ny7bk97vjV84FECcgldK8o_jH6H9afwL4C7ur</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1810651274</pqid></control><display><type>article</type><title>Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Lalic, Samanta ; Jamsen, Kris M. ; Wimmer, Barbara C. ; Tan, Edwin C.K. ; Hilmer, Sarah N. ; Robson, Leonie ; Emery, Tina ; Bell, J. Simon</creator><creatorcontrib>Lalic, Samanta ; Jamsen, Kris M. ; Wimmer, Barbara C. ; Tan, Edwin C.K. ; Hilmer, Sarah N. ; Robson, Leonie ; Emery, Tina ; Bell, J. Simon</creatorcontrib><description>Purpose The purpose of this study is to investigate the association between polypharmacy with health-related quality of life (HRQoL) and medication regimen complexity with HRQoL in residential aged care facilities (RACFs). Methods A cross-sectional study of 383 residents from six Australian RACFs was conducted. The primary exposures were polypharmacy (≥9 regular medications) and the validated Medication Regimen Complexity Index (MRCI). The outcome measure was staff informant rated quality of life assessed using the Quality of Life Alzheimer’s disease (QoL-AD) scale. Covariates included age, sex, Charlson’s comorbidity index, activities of daily living, and dementia severity. Logistic quantile regression was used to characterize the association between polypharmacy and QoL-AD (model 1) and MRCI and QoL-AD (model 2). Results The median age of the 383 residents was 88 years and 297 (78 %) residents were female. In total, 63 % of residents were exposed to polypharmacy and the median MRCI score (range) was 43.5 (4–113). After adjusting for the covariates, polypharmacy was not associated with either higher or lower QoL-AD scores (estimate −0.02; 95 % confidence interval (CI) −0.165, 0.124; p  = 0.78). Similarly, after adjusting for the covariates, MRCI was not associated with either higher or lower QoL-AD scores (estimate −0.0009, 95 % CI −0.005, 0.003; p  = 0.63). Conclusions These findings suggest that polypharmacy and medication regimen complexity are not associated with staff informant rated HRQoL. Further research is needed to investigate how specific medication classes may impact change in quality of life over time.</description><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/s00228-016-2075-4</identifier><identifier>PMID: 27251360</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Aged, 80 and over ; Australia ; Biomedical and Life Sciences ; Biomedicine ; Cross-Sectional Studies ; Drug therapy ; Drug Utilization ; Female ; Homes for the Aged - statistics &amp; numerical data ; Humans ; Male ; Nursing homes ; Older people ; Pharmacoepidemiology and Prescription ; Pharmacology ; Pharmacology/Toxicology ; Polypharmacy ; Quality of Life</subject><ispartof>European journal of clinical pharmacology, 2016-09, Vol.72 (9), p.1117-1124</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-ce639bbb137194bf66e14cf77f543ef79cd807f84ec1a6c17ff9f8a9e4ae45dd3</citedby><cites>FETCH-LOGICAL-c405t-ce639bbb137194bf66e14cf77f543ef79cd807f84ec1a6c17ff9f8a9e4ae45dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00228-016-2075-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00228-016-2075-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27251360$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lalic, Samanta</creatorcontrib><creatorcontrib>Jamsen, Kris M.</creatorcontrib><creatorcontrib>Wimmer, Barbara C.</creatorcontrib><creatorcontrib>Tan, Edwin C.K.</creatorcontrib><creatorcontrib>Hilmer, Sarah N.</creatorcontrib><creatorcontrib>Robson, Leonie</creatorcontrib><creatorcontrib>Emery, Tina</creatorcontrib><creatorcontrib>Bell, J. Simon</creatorcontrib><title>Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><addtitle>Eur J Clin Pharmacol</addtitle><description>Purpose The purpose of this study is to investigate the association between polypharmacy with health-related quality of life (HRQoL) and medication regimen complexity with HRQoL in residential aged care facilities (RACFs). Methods A cross-sectional study of 383 residents from six Australian RACFs was conducted. The primary exposures were polypharmacy (≥9 regular medications) and the validated Medication Regimen Complexity Index (MRCI). The outcome measure was staff informant rated quality of life assessed using the Quality of Life Alzheimer’s disease (QoL-AD) scale. Covariates included age, sex, Charlson’s comorbidity index, activities of daily living, and dementia severity. Logistic quantile regression was used to characterize the association between polypharmacy and QoL-AD (model 1) and MRCI and QoL-AD (model 2). Results The median age of the 383 residents was 88 years and 297 (78 %) residents were female. In total, 63 % of residents were exposed to polypharmacy and the median MRCI score (range) was 43.5 (4–113). After adjusting for the covariates, polypharmacy was not associated with either higher or lower QoL-AD scores (estimate −0.02; 95 % confidence interval (CI) −0.165, 0.124; p  = 0.78). Similarly, after adjusting for the covariates, MRCI was not associated with either higher or lower QoL-AD scores (estimate −0.0009, 95 % CI −0.005, 0.003; p  = 0.63). Conclusions These findings suggest that polypharmacy and medication regimen complexity are not associated with staff informant rated HRQoL. Further research is needed to investigate how specific medication classes may impact change in quality of life over time.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Australia</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cross-Sectional Studies</subject><subject>Drug therapy</subject><subject>Drug Utilization</subject><subject>Female</subject><subject>Homes for the Aged - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Male</subject><subject>Nursing homes</subject><subject>Older people</subject><subject>Pharmacoepidemiology and Prescription</subject><subject>Pharmacology</subject><subject>Pharmacology/Toxicology</subject><subject>Polypharmacy</subject><subject>Quality of Life</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkcFu1DAQhi0EokvhAbggS1y4BGYcJ465oYoWpEpwgHPkdcZbV0m8tR3BPhTviLNbEEJC4mTL8803tn_GniO8RgD1JgEI0VWAbSVANZV8wDYoa1EhSHzINgA1Vq1WcMaepHQLgI2G-jE7E0o0WLewYT8-h_GwvzFxMvbAzTzwiQZvTfZh5pF2fqKZ2zDtR_rucyESd8bmEFPZpmC9yTTwbz7f8JSNc9zPLhTZnHk8lu4WM66NwfHROyr1ok1-oDmn9dDsCmRNpNXrC-opveWG2xhSqhLZ9SZmLPZlODxlj5wZEz27X8_Z18v3Xy4-VNefrj5evLuurIQmV5baWm-3W6wVarl1bUsorVPKNbImp7QdOlCuk2TRtBaVc9p1RpM0JJthqM_Zq5N3H8PdQin3k0-WxtHMFJbUY4eNAtFp-T8oCt3WUhf05V_obVhiedyRgrZBoVYhnqjjD0Ry_T76ycRDj9Cvsfen2PsSe7_G3q89L-7Ny7bk97vjV84FECcgldK8o_jH6H9afwL4C7ur</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Lalic, Samanta</creator><creator>Jamsen, Kris M.</creator><creator>Wimmer, Barbara C.</creator><creator>Tan, Edwin C.K.</creator><creator>Hilmer, Sarah N.</creator><creator>Robson, Leonie</creator><creator>Emery, Tina</creator><creator>Bell, J. Simon</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160901</creationdate><title>Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study</title><author>Lalic, Samanta ; Jamsen, Kris M. ; Wimmer, Barbara C. ; Tan, Edwin C.K. ; Hilmer, Sarah N. ; Robson, Leonie ; Emery, Tina ; Bell, J. Simon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-ce639bbb137194bf66e14cf77f543ef79cd807f84ec1a6c17ff9f8a9e4ae45dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Australia</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cross-Sectional Studies</topic><topic>Drug therapy</topic><topic>Drug Utilization</topic><topic>Female</topic><topic>Homes for the Aged - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Male</topic><topic>Nursing homes</topic><topic>Older people</topic><topic>Pharmacoepidemiology and Prescription</topic><topic>Pharmacology</topic><topic>Pharmacology/Toxicology</topic><topic>Polypharmacy</topic><topic>Quality of Life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lalic, Samanta</creatorcontrib><creatorcontrib>Jamsen, Kris M.</creatorcontrib><creatorcontrib>Wimmer, Barbara C.</creatorcontrib><creatorcontrib>Tan, Edwin C.K.</creatorcontrib><creatorcontrib>Hilmer, Sarah N.</creatorcontrib><creatorcontrib>Robson, Leonie</creatorcontrib><creatorcontrib>Emery, Tina</creatorcontrib><creatorcontrib>Bell, J. Simon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lalic, Samanta</au><au>Jamsen, Kris M.</au><au>Wimmer, Barbara C.</au><au>Tan, Edwin C.K.</au><au>Hilmer, Sarah N.</au><au>Robson, Leonie</au><au>Emery, Tina</au><au>Bell, J. Simon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study</atitle><jtitle>European journal of clinical pharmacology</jtitle><stitle>Eur J Clin Pharmacol</stitle><addtitle>Eur J Clin Pharmacol</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>72</volume><issue>9</issue><spage>1117</spage><epage>1124</epage><pages>1117-1124</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><abstract>Purpose The purpose of this study is to investigate the association between polypharmacy with health-related quality of life (HRQoL) and medication regimen complexity with HRQoL in residential aged care facilities (RACFs). Methods A cross-sectional study of 383 residents from six Australian RACFs was conducted. The primary exposures were polypharmacy (≥9 regular medications) and the validated Medication Regimen Complexity Index (MRCI). The outcome measure was staff informant rated quality of life assessed using the Quality of Life Alzheimer’s disease (QoL-AD) scale. Covariates included age, sex, Charlson’s comorbidity index, activities of daily living, and dementia severity. Logistic quantile regression was used to characterize the association between polypharmacy and QoL-AD (model 1) and MRCI and QoL-AD (model 2). Results The median age of the 383 residents was 88 years and 297 (78 %) residents were female. In total, 63 % of residents were exposed to polypharmacy and the median MRCI score (range) was 43.5 (4–113). After adjusting for the covariates, polypharmacy was not associated with either higher or lower QoL-AD scores (estimate −0.02; 95 % confidence interval (CI) −0.165, 0.124; p  = 0.78). Similarly, after adjusting for the covariates, MRCI was not associated with either higher or lower QoL-AD scores (estimate −0.0009, 95 % CI −0.005, 0.003; p  = 0.63). Conclusions These findings suggest that polypharmacy and medication regimen complexity are not associated with staff informant rated HRQoL. Further research is needed to investigate how specific medication classes may impact change in quality of life over time.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27251360</pmid><doi>10.1007/s00228-016-2075-4</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6970
ispartof European journal of clinical pharmacology, 2016-09, Vol.72 (9), p.1117-1124
issn 0031-6970
1432-1041
language eng
recordid cdi_proquest_miscellaneous_1815702894
source MEDLINE; SpringerNature Journals
subjects Aged
Aged, 80 and over
Australia
Biomedical and Life Sciences
Biomedicine
Cross-Sectional Studies
Drug therapy
Drug Utilization
Female
Homes for the Aged - statistics & numerical data
Humans
Male
Nursing homes
Older people
Pharmacoepidemiology and Prescription
Pharmacology
Pharmacology/Toxicology
Polypharmacy
Quality of Life
title Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A04%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polypharmacy%20and%20medication%20regimen%20complexity%20as%20factors%20associated%20with%20staff%20informant%20rated%20quality%20of%20life%20in%20residents%20of%20aged%20care%20facilities:%20a%20cross-sectional%20study&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=Lalic,%20Samanta&rft.date=2016-09-01&rft.volume=72&rft.issue=9&rft.spage=1117&rft.epage=1124&rft.pages=1117-1124&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/s00228-016-2075-4&rft_dat=%3Cproquest_cross%3E4144310521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1810651274&rft_id=info:pmid/27251360&rfr_iscdi=true